Metal–organic framework nanocarriers for drug delivery in biomedical applications

Y Sun, L Zheng, Y Yang, X Qian, T Fu, X Li, Z Yang… - Nano-Micro Letters, 2020 - Springer
Investigation of metal–organic frameworks (MOFs) for biomedical applications has attracted
much attention in recent years. MOFs are regarded as a promising class of nanocarriers for …

Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches

TB Emran, A Shahriar, AR Mahmud, T Rahman… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …

Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy

W Zeng, H Zhang, Y Deng, A Jiang, X Bao… - Chemical Engineering …, 2020 - Elsevier
Photonic therapy (eg, photodynamic therapy (PDT) and photothermal therapy (PTT)),
features easy handling, good targeting, high curative effect and lower side effects compared …

Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water‐soluble drugs

W Xu, P Ling, T Zhang - Journal of drug delivery, 2013 - Wiley Online Library
Oral administration is the most commonly used and readily accepted form of drug delivery;
however, it is find that many drugs are difficult to attain enough bioavailability when …

Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy

P Parhi, C Mohanty, SK Sahoo - Drug discovery today, 2012 - Elsevier
Combination therapy for the treatment of cancer is becoming more popular because it
generates synergistic anticancer effects, reduces individual drug-related toxicity and …

Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

M Majidinia, M Mirza‐Aghazadeh‐Attari, M Rahimi… - IUBMB …, 2020 - Wiley Online Library
Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both
conventional and novel chemotherapy agents, is an important barrier in treating …

Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor

Q Yin, J Shen, Z Zhang, H Yu, Y Li - Advanced drug delivery reviews, 2013 - Elsevier
Multidrug resistance (MDR) is a major obstacle to successful cancer therapy, especially for
chemotherapy. The new drug delivery system (DDS) provides promising approaches to …

Nanodrug delivery in reversing multidrug resistance in cancer cells

S Kapse-Mistry, T Govender, R Srivastava… - Frontiers in …, 2014 - frontiersin.org
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …

Co-encapsulation systems for delivery of bioactive ingredients

K Liu, YY Chen, LH Pan, QM Li, JP Luo… - Food Research …, 2022 - Elsevier
To improve the solubility, stability and bioavailability of bioactive compounds, a series of
delivery systems have been designed and developed in recent years. However, most …

Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer

M Liu, M Fu, X Yang, G Jia, X Shi, J Ji, X Liu… - Colloids and Surfaces B …, 2020 - Elsevier
Multidrug resistance (MDR) in tumor has long been considered a major factor in the failure
of tumor chemotherapy. P-glycoprotein (P-gp)-mediated drug efflux plays a significant role in …